Press Releases

Date	Title
1/7/19	Pulse Biosciences Announces Positive Clinical Results of Its Nano-Pulse Stimulation™ Technology Platform to Treat Patients with Sebaceous Hyperplasia Lesions on the Face
12/17/18	Pulse Biosciences Grants Equity Incentive Awards to New Employees
12/14/18	Pulse Biosciences, Inc. Announces Closing of Its $45 Million Rights Offering
12/7/18	Pulse Biosciences, Inc. Announces Oversubscription, Pricing and Preliminary Results for Its $45 Million Rights Offering
11/19/18	Pulse Biosciences, Inc. Announces Commencement of Rights Offering
11/15/18	Pulse Biosciences Grants Equity Incentive Awards to New Employees
11/7/18	Pulse Biosciences, Inc. Announces Record Date, Subscription Pricing, and Expiration Date for Rights Offering and Effectiveness of Its Registration Statement
10/30/18	Pulse Biosciences Quarterly Investor Conference Call
10/25/18	Pulse Biosciences Files Registration Statement for Rights Offering
10/23/18	Pulse Biosciences to Report Third Quarter 2018 and Operational Highlights and Financial Results

Keyword Search